Teadusartiklid ja suulised ettekanded
Teadusartiklid
Uusküla A, Laisaar KT, Raag M, Lemsalu L, Lõhmus L, Rüütel K, Amico KR; HIV-BRIDGE Study Group.Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS Behav. 2017 Jul 17. doi: 10.1007/s10461-017-1859-6
Huik, K; Soodla, P; Rajasaar, H; Pauskar, M; Jõgeda, E; Kallas, E; Zilmer, K; Maimets, M; Kink, K; Semjonova, S; Kirs, K; Lutsar, I; Avi, R Virologic response to antiretroviral treatment in an Estonian HIV cohort study in 2015 (2017) 21th International Workshop on HIV Observational Databases
Laisaar, KT; Raag, M; Lutsar, I; Uusküla, A People living with HIV in Estonia: engagement in HIV care in 2013. Euro Surveill.2016Oct 27;21(43)
Kallas, E; Huik, K; Türk, S; Pauskar, M; Jõgeda, E; Šunina, M; Karki, T; Des Jarlais, D; Uusküla, A; Avi, R; Lutsar, I (2017). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical microbiology and immunology, 205 (3), 231−239
Kallas, E; Huik, K; Türk, S; Pauskar, M; Jõgeda, E; Šunina, M; Karki, T; Des Jarlais, D; Uusküla, A; Avi, Radko; Lutsar, I (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral immunology, 0−0.
Rhee, S.-Y.; Blanco, J.L.; Jordan, M.R.; Taylor, J.; Lemey, P.; Varghese, V.; Hamers, R.L.; Bertagnolio, S.; de Wit, T.F.R.; Aghokeng, A.F.; Albert, J.; Avi, R.; Avila-Rios, S.; Bessong, P.O.; Brooks, J.I.; Boucher, C.A.B.; Brumme, Z.L.; Busch, M.P.; Bussmann, H.; Chaix, M.-L.; Chin, B.S.; DâAquin, T.T.; De Gascun, C.F.; Derache, A.; Descamps, D.; Deshpande, A.K.; Djoko, C.F.; Eshleman, S.H.; Fleury, H.; Frange, P.; Fujisaki, S.; Harrigan, P.R.; Hattori, J.; Holguin, A.; Hunt, G.M.; Ichimura, H.; Kaleebu, P.; Katzenstein, D.; Kiertiburanakul, S.; Kim, J.H.; Kim, S.S.; Li, Y.; Lutsar, I.; Morris, L.; Ndembi, N.; NG, K.P.; Paranjape, R.S.; Peeters, M.; Poljak, M.; Price, M.A.; Ragonnet-Cronin, M.L.; Reyes-Terán, G.; Rolland, M.; Sirivichayakul, S.; Smith, D.M.; Soares, M.A.; Soriano, V.V.; Ssemwanga, D.; Stanojevic, M.; Stefani, M.A.; Sugiura, W.; Sungkanuparph, S.; Tanuri, A.; Tee, K.K.; Truong, H.-H.M.; van de Vijver, D.A.M.C.; Vidal, N.; Yang, C.; Yang, R.; Yebra, G.; Ioannidis, J.P.A.; Vandamme, A.-M.; Shafer, R.W. (2015). Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis (PLoS Medicine). PLOS Medicine, 12(4), 1001810
Kaitstud doktoritööd
Kallas Eveli The influence of immunological markers to susceptibility to HIV, HBV, and HCV infections among persons who inject drugs (2017)
Kaja-Triin Laisaar People living with HIV in Estonia: Engagement in medical care and methods of increasing adherence to antiretroviral therapy and safe sexual behavior (2016)
Kristi Huik The influence of host genetic factors on the susceptibility to HIV and HCV infections among intravenous drug users (2014)
Doktoritööd kirjutamisel
Pilleriin Soodla Estimation of early HIV infection in Estonia (Varajase HIV infektsiooni leviku hindamine Eestis)
Suulised ettekanded
Kallas, E.; Avi, R.; Huik, K.; Türk, S.; Pauskar, M.; Jõgeda, E.-.L.; Šunina, M.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2015). The distribution of TEMRA cells is influenced by HIV, HBV, HCV infections and intravenous drug use. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Pauskar, M; Avi, R.; Kallas, E.; Jõgeda, E-L.; Karki, T.; Uusküla, A.; Des Jarlais, D; Lutsar, I.; Huik, K. Association between IL28B rs12979860 genotypes and susceptibility to HCV and/or HIV infection in Caucasian intravenous drug users. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Kase, K.; Rajasaar, H.; Avi, R.; Pauskar, M.; Zilmer, K.; Kink, K.; Novikova, L.; Maimets, M.; Lutsar, I.; Huik, K. Co-infection with hepatitis C virus in Estonian HIV population during last two decades. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Soodla, P.; Rajasaar, H.; Maimets, M.; Lutsar, I. The Estonian HIV Cohort Study: Participant Characteristics Over Time. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Avi, R.; Huik, K.; Pauskar, M.; Kallas, E.; Jõgeda, E.-L.; Zilmer, K.; Ustina, V.; Novikova, L.; Karki, T.; Kisand, V.; Lutsar, I. (2014). Full-Length Genome Sequences of Estonian HIV-1 CRF06 and Eastern-European Subtype A1 Recombinant Forms. 7th National Congress HIV/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.
Jõgeda, E.-L.; Huik, K.; Avi, R; Pauskar, M., Kallas, E.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). Associations between MX2 polymorphism and the acquisition of HIV and co-infections in Caucasian intravenous drug users (IDUs). European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.
Kallas, E.; Avi, R.; Huik, K.; Türk, S.; Pauskar, M.; Jõgeda, E.-.L.; Šunina, M.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). Injection drug use influences T-cell distribution and CCR5 expression in HIV+ and ESN population. 24th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona; 10-13 May 2014.
Kallas, E.; Huik, K.; Avi, R; Pauskar, M.; Jõgeda, E.-L.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). NLRP3 genotype CG increases the risk of HIV-1 in Caucasian intravenous drug users (IDUs). European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.
Pauskar, M.; Huik, K.; Avi, R.; Kallas, E.; Jõgeda, E.-L.; Karki, T.; Semjonova, S.; Smidt, J.; Novikova, L.; Ainsalu, K.; Lutsar, I. (2014). Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy. 7th National Congress HIV/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.
Avi, R; Huik, K; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Šmidt, J; Novikova, L; Semjonova, S; Lutsar, I. (2013). Substitutions in RNaseH and Connection domain of HIV-1 CRF06_cpx viruses in treatment naive and treatment experienced populations. 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 35 - 35.
Jõgeda, EL; Huik, K; Pauskar, M; Kallas, E; Krispin, T; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Avi, R; Lutsar, I. (2013). The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users. In: Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 46 - 47.
Kallas, E; Huik, K; Avi, R; Pauskar, M; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). The IL-10 promoter genotype AA at -592 is correlated with increased susceptibility to hepatitis B but not HIV infection in Caucasian intravenous drug users. European Human Genetics Conference 2013, Paris, France, 8.06.13-11.06.13.